日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors

吉西他滨耐药的胰腺癌细胞系获得侵袭性表型,并对组蛋白去乙酰化酶抑制剂产生附带超敏反应

Betty K Samulitis, Kelvin W Pond, Erika Pond, Anne E Cress, Hitendra Patel, Lee Wisner, Charmi Patel, Robert T Dorr, Terry H Landowski

Characterization of a membrane-active anti-tumor agent, UA8967

膜活性抗肿瘤剂UA8967的特性分析

Dorr, Robert T; Samulitis, Betty K; Wisner, Lee; Han, Haiyong; Zhao, Yu; Beroza, Paul; Damodaran, Komath; Igarashi, Suzu; Landowski, Terry H; Von Hoff, Daniel D

Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells

Imexon 诱导胰腺癌细胞的氧化内质网应激反应

Elena V Sheveleva, Terry H Landowski, Betty K Samulitis, Geoffrey Bartholomeusz, Garth Powis, Robert T Dorr

Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance

抗氧化防御能力增强的淋巴瘤细胞获得化学耐药性

Margaret E Tome, Jennifer B Frye, Donna L Coyle, Elaine L Jacobson, Betty K Samulitis, Katerina Dvorak, Robert T Dorr, Margaret M Briehl

Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423

氰基氮丙啶衍生物AMP423的抗肿瘤活性及其作用机制

Dorr, Robert T; Wisner, Lee; Samulitis, Betty K; Landowski, Terry H; Remers, William A

Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase

Imexon通过抑制核糖核苷酸还原酶增强吉西他滨的细胞毒性

Roman, Nicholas O; Samulitis, Betty K; Wisner, Lee; Landowski, Terry H; Dorr, Robert T

Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells

伊美克松抑制蛋白质合成可降低常氧和缺氧胰腺癌细胞中HIF-1α的表达。

Samulitis, Betty K; Landowski, Terry H; Dorr, Robert T

Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines

在A375人黑色素瘤细胞系和RPMI 8226人骨髓瘤细胞系中,基于伊美沙酮的联合化疗方案

Scott, Julie; Dorr, Robert T; Samulitis, Betty; Landowski, Terry H